FDA panel backs Pfizer Covid-19 vaccine for 5- to 11-year-olds
Published
Data from drugmaker and US regulator suggest advantages of Covid-19 jab would far outweigh risks
Full ArticlePublished
Data from drugmaker and US regulator suggest advantages of Covid-19 jab would far outweigh risks
Full Article“Contagious” brain disorders? “Deceptive” COVID shot marketing? “Nonsense” from the FDA? “Incentivized” killing in..